Grace Therapeutics, Inc.

GRCE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 21, 2026 4
4 Oct 16, 2026 4
4 Oct 13, 2026 4
4 Oct 5, 2026 4
4 Oct 1, 2026 4
4/A Oct 1, 2026 4/A
4 Sep 23, 2026 4
4 Sep 21, 2026 FORM 4
4 Sep 21, 2026 FORM 4
4 Sep 21, 2026 FORM 4
4 Sep 21, 2026 FORM 4
8-K Sep 18, 2026 8-K
4 Sep 10, 2026 4
4 Sep 10, 2026 FORM 4
4 Sep 1, 2026 FORM 4
4 Sep 1, 2026 FORM 4
4 Sep 1, 2026 FORM 4
4 Sep 1, 2026 FORM 4
EFFECT Aug 31, 2026
S-3 Aug 24, 2026 S-3
4 Aug 19, 2026 4
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 13, 2026 8-K
10-Q Aug 13, 2026 10-Q
← Newer Page 1 of 24 · 592 filings Older →